Sell AbbVie Stock Ahead of Its Upcoming Earnings?

AbbVie (ABBV) is scheduled to report earnings on July 31, 2025, with consensus estimates at $2.91 EPS on $15.03 billion in sales. Historically, the stock has shown a significant tendency for negative one-day returns post-earnings, occurring in 65% of instances over the past five years with a median decline of -1.3% and a maximum drop of -7.3%. Positive one-day returns have been observed in only about 35% of cases over five years, decreasing to 17% over the last three years, indicating a notable historical downside bias for the stock following its announcements.

Analysis

AbbVie (ABBV) is approaching its July 31, 2025 earnings announcement with consensus estimates projecting year-over-year growth, with earnings per share expected at $2.91 on $15.03 billion in sales, compared to $2.65 and $14.46 billion respectively in the prior year. Despite this positive fundamental outlook, historical data reveals a significant negative bias in the stock's immediate post-earnings performance. Over the past five years, ABBV has experienced a negative one-day return following 65% of its earnings announcements, with a median decline of -1.3%. This bearish pattern appears to be intensifying, as the frequency of positive one-day returns has diminished from 35% over the last five years to just 17% over the most recent three-year period. This historical price action suggests that even if the company meets or beats its solid growth estimates, the stock is statistically more likely to face selling pressure on the day of the report.

Key Decisions for Investors

• Given the strong historical precedent for a negative post-earnings reaction, investors holding long positions in AbbVie should be prepared for potential short-term downside volatility immediately following the July 31st announcement.
• Event-driven traders may consider the stock's historical tendency to decline, with negative one-day returns in 65% of cases, as a basis for tactical short positioning or purchasing protective puts ahead of the report.
• Investors should note the potential disconnect between positive fundamental growth expectations and the negative historical price action, suggesting the market's reaction may be driven more by positioning and sentiment than the headline numbers.
• Following the release, traders should assess the correlation between the initial one-day return and subsequent medium-term performance to identify potential entry or exit points for the following weeks.